In this communication, the effect of acute treatment with lamotrigine (LTG) and topiramate (TPM) was investigated on release of the main excitatory amino acids (EAA) such as glutamate (Glu) and aspartate (Asp) in the hippocampus of pentylenetetrazol (PTZ)-kindled freely moving rats using microdialysis. The results showed that the level of Glu and Asp significantly decreased in the PTZ-kindled epileptic (EP) rat hippocampus after the 20 mg/kg LTG or 40 mg/kg TPM administration. But LTG gave rise to a better result than TPM in controlling EAA release.
cerebrospinal fluid (CSF), and no change of Glu concentration was discovered either. Other studies have found that 8 LTG could not reduce the neurotransmitter release of N-methyl-D-aspartic acid (NMDA) receptor regulation, which could be effectively regulated by the addition of a low dose of NMDA receptor antagonist. Moreover, it was found that LTG reduced the release of Glu by inhibiting the binding between Glu and the postsynaptic -amino-3-hydroxy-5-methyl-4-isoxa-zolep-propionate (AMPA) receptor. 9 TPM inhibited convulsions induced by amygdale-kindled seizures and posttraumatic epilepsy in rats. 10 11 Labate et al. 12 confirmed that TPM is particularly effective and very well tolerated in patients with mild temporal lobe epilepsy. For refractory partial epilepsy, TPM as an adjunctive treatment was effective and well-tolerated in elderly patients. 13 Study suggested that TPM could reduce abnormal level of EAA in the hippocampus of the spontaneously epileptic rat 14 TPM has also been showed to block the excitatory currents of the AMPA and kainic acid in neurons and glia 15 16 and voltage-activated Na + and Ca 2+ channels, 17 18 which perhaps affects Glu release.
Recently, biomedical nanotechnology is finding more and more application. The present study is a side-by-side comparison assessing of the effectiveness of LTG and TMP on EAA release in PTZ-kindled rat hippocampus with the help of microdialysis a kind of newly developed biomedical nanotechnology. In the study, dose of 20 mg/kg LTG 5 and 40 mg/kg TPM 14 were applied. Adult male Sprague-Dawley rats (180-230 g) were employed for the experiments (Shanghai Experimental Animal Center, Chinese Academy of Science). Five rats were kept in individual cages with water and food available ad libitum. The animal room was maintained at 21-23 C, with a 12 h light-dark cycle. All experimental procedures were approved by the Committee of Laboratory Animals, Chinese Academy of Science.
For drug treatment, young rats were intraperitoneally administered with subconvulsive dose of 1% PTZ (dissolved in saline, 40 mg/kg; Sigma) three times per week (Monday, Wednesday, Friday). Control animals received the same number of saline injections. After each injection, behaviors were observed for 30 min for the occurrence of generalized clonic seizures. 20 Susceptibility to seizures was evaluated 30 days after last injection while 87.1% of the rats (n = 26) were kindled successfully by PTZ. To maintain the epileptic state of the kindled rats, the same dosage of PTZ was administered once a week until the microdialysis analysis was performed.
The seizures were rated according to the following criteria. 41 Stage 0, no response; Stage I, ear and facial twitching; Stage II, myoclonic jerks without upright position; Stage III, myoclonic jerks, upright position with bilateral forelimb clonus; Stage IV, clonic-tonic seizure; Stage V, clonic-tonic seizures took place, postural control was lost.
For surgery and microdialysis, rats (180-350 g) were anaesthetized with pentobarbital (40 mg/kg, i.p.). Intracerebral guide cannula was implanted (CMA11, CMA, Sweden) into brain (coordinates: P = −5 2 mm; L/R = ±4 4 mm relative to bregma; H = −5 mm relative to the dural surface) with a stereotaxic instrument. After a 48 h recovery period, the rats were anesthetized by ether absolute. Microdialysis probe (4 mm membrane length, CMA11, CMA, Sweden) was implanted into the rat hippocampus through a guide cannula, then perfused with artificial cerebral spinal fluid (ACSF) possessing a composition in mM: NaCl 125, KCl 2.5, MgCl 2 1.18, CaCl 2 1.26, pH 7.4 at a flow rate of 1 L/min with a micro-syringe pump (CMA, Sweden) in the conscious freely moving rat. After an initial 2 h equilibrium period, two basal dialysate samples were collected every 30 min. 42 It was found that acute administration of 20 mg/kg LTG or 40 mg/kg TPM was effective dose. 5 14 Experimental rats were divided into four groups as follows. Group 1: rats treated with saline were i.p. injected with saline. Group 2: epileptic rats kindled by PTZ were i.p. injected with a dose of 40 mg/kg PTZ. Group 3: PTZ-kindled epileptic rats were i.p. coadministered with a dosage of 40 mg/kg PTZ plus a dosage of 20 mg/kg LTG (dissolved in ddH 2 O + 50% isopropanol; Sigma). Group 4: PTZ-kindled epileptic rats were i.p. coadministered with a dose of 40 mg/kg PTZ plus a dose of 40 mg/kg TPM (dissolved in the ACSF; Sigma). Samples were collected every 30 min continually for 5 h, and then stored at −70 C until analysis.
When the experiment was terminated, the rats were i.p. administered with an overdose of pentobarbital, and the brains were fixated in 10% formalin solution. Coronal section (60 m thick) was sliced to verify the probes placement.
Excitatory amino acid (Glu and Asp) releases were measured by the O-Phthaldialdehyde ((OPA), Sigma) assay, using Glu and Asp as standard. Solution of pre-column derivatization was prepared: 25 mg of OPA was dissolved in 0.5 mL methanol and 5 mL 0. The derivatization was performed using the mixture of 25 L microdialysis sample and 25 L OPA solution. After 1.5 min, the sample was injected into the column. Concentrations of amino acids were measured by reverse phase-HPLC system with a 1200 fluorescence detector (G1321A, Agilent, USA) on an Agilent 1200 HPLC system, using a C 18 analytical column (250 mm × 4.6 mm, 5 m). The wavelength used for measuring the derivatives was ex.338/em.446 nm.
For statistics analysis, data were shown as mean ± standard error of mean (SEM) of the percentage of baseline concentrations, analyzed by Student's paired t-test, and compared by one-way analysis of variance (ANOVA) followed by Fisher's post hoc test. P < 0 05 was considered to be significant.
Following the application of LTG (20 mg/kg) and TPM (40 mg/kg), rats in normal + saline (NS) treated group were sedated in comparison with their pre-administration states. After 40 mg/kg PTZ administration, the kindled epileptic rats (group 2) suffered more than five times of seizure activity ( ≥ Stage II) within 30 min. However, after co-administration of 40 mg/kg plus 20 mg/kg LTG (Group 3) or 40 mg/kg TPM (Group 4), only individual epileptic rats displayed two to three times of light seizure behavior within 30 min and no seizure behavior after 5 h in co-treated group. Effect of 20 mg/kg LTG and 40 mg/kg TPM on 40 mg/kg PTZ induced seizure grade are showed in Table I . The doses of LTG and TPM were chosen as the most promising in previous experiments. 5 14 In PTZ + TPM and PTZ + LTG co-treated EP rats, most rats showed only grade III, II and I seizures, even grade 0. But it was showed grade III contained one more rat in the TPM group than LTG group. To check EAA release baseline of kindled epileptic rat hippocampus, basal EAA levels in (NS) and kindled epileptic rats are showed in Table II . The levels of Glu and Asp are significantly higher than those in saline-treated (NS) groups (P < 0 01), respectively.
Comparison of EAA release inhibition of LTG and TPM treatment in the kindled epileptic rat hippocampus was carefully made. For comparison of Glu release inhibition in the kindled epileptic rat hippocampus, after co-administration of PTZ and LTG (group 2), the Glu concentration decreased markedly and maintained at near EP baseline during 90∼240 min, and was lower than the EP baseline level, closing to NS baseline level, at 240 min. Then it approached NS baseline level during 240∼360 min (Fig. 1) . After co-administration of PTZ and TPM (group 3), the Glu concentration decreased markedly and was lower than the EP baseline level during 90∼150 min, and was near EP baseline (113%) at 180 min, 360 min time points (Fig. 1) . The group co-administered with PTZ and LTG (group 2) or TPM (group 3) compared with the EP group displayed extremely distinct effect (P < 0 01) at 90, 120, 180, 240, 270, 330 and 360 min time points, and marked effect (P < 0 05) at 210 and 300 min time points. However, the group 2 compared with the group 3 showed no statistical significance. Relatively, the Glu concentration of group 3 fluctuated more apparently than that of group 2, and rose again. That of group 2 declined slowly all along and approached NS baseline level. Table II . Basic level of EAA neurotransmitter in NS and PTZkindled epileptic rat hippocampus.
NS rat
Kindled-epileptic rat ( mol/L, n = 7) ( mol/L, n = 8) * P < 0 05, * * P < 0 01, ANOVA compared with 40 mg/kg PTZ injection epileptic rats and co-administrated of 40 mg/kg PTZ plus 20 mg/kg LTG in epileptic rats; # P < 0 05, ## P < 0 01, ANOVA compared with 40 mg/kg PTZ injection epileptic rats and co-administrated of 40 mg/kg PTZ plus 40 mg/kg TPM in epileptic rats.
* and # denote significant difference, and * * and ## very significant difference.
The Asp release inhibition was also carefully checked. Similar to the Glu release state in the kindled epileptic rat hippocampus, after co-administration of PTZ and LTG, the Asp concentration decreased markedly and maintained at near EP baseline during 90∼210 min, then dropped to near NS baseline level at 210 min and finally approached NS baseline level during 300∼360 min (Fig. 2) . After coadministration of PTZ and TPM (group 3), the Asp concentration decreased markedly and became lower than the EP baseline level during 90∼150 min, approaching EP baseline level during 180∼360 min (Fig. 1) . The group co-administered with PTZ + LTG (grpup 2) or PTZ + TPM (group 3) in comparison with the EP group showed an extremely marked effect (P < 0 01) at 90, 120, 180, 210, 240 and 270 min time points. Likewise, it was showed no statistical significance was presented for the group 2 compared with the group 3. And the Asp concentration of group 3 approached EP baseline level which had marked significance in comparison with NS baseline, while that of group 2 decreased slowly all along and approached NS baseline level.
According to literature, LTG and TPM are two new antiepileptic agents with multifactorial mechanisms of action. Both clinical and experimental studies suggested seizures-related changes in the EEA levels in the brain. [43] [44] [45] It has been proposed that the glutamatergic system could be altered by PTZ-kindling. 46 47 Glu release was increased in the initial phase of PTZ-kindling, whereas in the late phase Glu binding sites were raised. 48 An increase of [ 3 H] glutamate (sensitive component of NMDA receptor) binding was observed in the hippocampus after acquisition of the PTZ-kindled rats. 49 In the PTZ-kindled rat hippocampus, the levels of Glu and Asp were significantly increased in our study. The results from our study (Table II) are very close to that found by Li et al. 42 Both LTG and TPM have the mechanism to reduce EAA release. 5 14 In this study, we have investigated and compared the effects of LTG and TPM on PTZ induced release of EEA in the hippocampus of freely moving rats, such as Glu and Asp. LTG is considered to mediate a reduction in Glu release arising from an inhibitory effect on type II Na + channels. [50] [51] [52] Additionally, it is also important that inhibition of Ca + channels is taken as part of the mechanism of action of the drug. 2 53 TPM is considered to modify Na + and/or Ca 2+ dependent action potentials, enhance GABA-mediated Cl − flux into neurons, and inhibit kainite-mediated conductance at Glu receptors of the AMPA/Kainate type. 54 Yilmaz et al. 18 investigated that TPM also modulated NMDA receptors by Ca 2+ homeostasis. Our current study results show that the concentration of Glu in PTZ + LTG and PTZ + TPM co-treated rat hippocampus was significantly decreased in comparison with that in PTZ-treated rats. Moreover, Asp release is as same as that of Glu in excitatory terminals in hippocampus. 55 56 In the EP rat hippocampus, after 20 mg/kg LTG or 40 mg/kg TPM administration into PTZ-kindled rats, the levels of Glu and Asp significantly decreased, but slowly approached to basic level of NS group for LTG group and approached to that of EP group for TPM group. It was found that Glu and Asp concentrations displayed significant difference for PTZkindled group in comparison with PTZ + LTG or PTZ + TPM co-treated group (P < 0 01) ( Fig. 1 and 2 ), but Glu and Asp releases have no statistical significance between PTZ + LTG co-treated group and PTZ + TPM co-treated group. The results show that both LTG and TPM reduced the release of Glu and Asp, and the dosage of 20 mg/kg LTG and 40 mg/kg TPM used in the present study is well within the therapeutic index for EAA release induced by PTZ. 5 14 But EAA release inhibition of LTG is more effective than that of TPM. The result is very close to that showed Table I From all above, the levels of Glu and Asp significantly increased in EP rat hippocampus. After 20 mg/kg LTG or 40 mg/kg TPM administration into the PTZ-treated group, extracellular EAA concentration significantly decreased. The results indicate that main EAA's release was inhibited after acute LTG treatment in the hippocampus of PTZinduced and kindled epileptic rats. But LTG was better than TPM in controlling EAA release.
